FAS and Autoimmunity: We provide evidence that a small subset of CD4+IL-6R+ TEM cells from carriers of the “non-risk/CC’ genotype show higher sensitivity to FAS agonist-induced expression of early apoptotic markers (Annexin V+ cells), potentially leading to decreased survival of pathogenic T cells in autoimmunity.